ILA 28.6% 13.5¢ island pharmaceuticals limited

Ann: Investor webinar, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,584 Posts.
    lightbulb Created with Sketch. 1416
    Daniel I agree that $3.5m couldn't have been raised from retail.
    But it didn't need to all, or even mostly, come from retail.

    Are you suggesting there was no element of marketing failure by the Board contributing to the "liquidity trap"?

    Interesting that there being no SPP was made a condition of the placement offer, and that the Board accepted that condition. IMO that acceptance reflects very poorly on the Board.

    IMO you're overstating the liquidity risk. Turnover has suddenly boomed. And why even mention it if you're not intending to sell?

    And why assume that all retail would have flipped? Not all retail are stupid and impatient. Some would have flipped and some would have held. Look at the bisantrene company.
 
watchlist Created with Sketch. Add ILA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.